Rallybio RLYB
NASDAQ RLYB
$16.83 +0.23 (+1.39%)
As of: Aug 21, 2026 · 3:59 PM EDT

Rallybio (RLYB) Non Operating Income (2020 - 2026)

Rallybio (RLYB) posted Non Operating Income of $455000.0 for Q1 2026, down 18.75% sequentially from $560000.0 in Q4 2025, and down 44.38% YoY from $818000.0 in Q1 2025.

Rallybio (RLYB) Non Operating Income (2020 - 2026) Analysis & Trends

Rallybio has reported Non Operating Income for 7 years, with the latest figure at $455000.0 in Q1 2026.

  • Quarterly Non Operating Income fell 44.38% year-over-year to $455000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.6 million (up 467.4% YoY) and the FY2025 annual result came in at $25.0 million, up 403.23% from the prior year.
  • Non Operating Income eased to $455000.0 in Q1 2026 per RLYB's latest filing, from $560000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $22.9 million in Q3 2025 and troughed at $210000.0 in Q1 2022.
  • A 5-year average of $2.3 million and a median of $1.1 million in 2022 frame the typical range for Non Operating Income.
  • The widest YoY moves for Non Operating Income: up 1754.57% in 2025, down 50.16% in 2025.
  • Over 5 years, Non Operating Income stood at $1.1 million in 2022, then jumped by 34.57% to $1.5 million in 2023, then sank by 32.97% to $994000.0 in 2024, then sank by 43.66% to $560000.0 in 2025, then fell by 18.75% to $455000.0 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $455000.0, $560000.0, and $22.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -53.64 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -51.63 Mn
10 Rallybio 94.61 Mn 94.61 Mn - 50.64 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 50.64 Mn
Mar 31, 2026 455,000.00
Dec 31, 2025 560,000.00
Sep 30, 2025 22.94 Mn
Jun 30, 2025 641,000.00
Mar 31, 2025 818,000.00
Dec 31, 2024 994,000.00
Sep 30, 2024 1.24 Mn
Jun 30, 2024 1.29 Mn
Mar 31, 2024 1.44 Mn
Dec 31, 2023 1.48 Mn
Sep 30, 2023 1.64 Mn
Jun 30, 2023 1.67 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 623,000.00
Jun 30, 2022 370,000.00
Mar 31, 2022 210,000.00
Dec 31, 2021 121,000.00
Sep 30, 2021 117,000.00